BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29626323)

  • 1. The Case for a Private Healthcare Insurance Monopoly.
    Orzechowski PE
    Appl Health Econ Health Policy; 2018 Aug; 16(4):433-443. PubMed ID: 29626323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Critical Analysis of Obamacare: Affordable Care or Insurance for Many and Coverage for Few?
    Manchikanti L; Helm Ii S; Benyamin RM; Hirsch JA
    Pain Physician; 2017 Mar; 20(3):111-138. PubMed ID: 28339427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The health policy election.
    Carroll AE; Frakt AB
    JAMA; 2012 Oct; 308(16):1633-4. PubMed ID: 23060272
    [No Abstract]   [Full Text] [Related]  

  • 4. Business of Health: Business of Health Insurance.
    Berry MD;
    Issue Brief Health Policy Track Serv; 2015 Dec; ():1-87. PubMed ID: 27116765
    [No Abstract]   [Full Text] [Related]  

  • 5. Regulating self-selection into private health insurance in Chile and the United States.
    Vargas Bustamante A; Méndez CA
    Int J Health Plann Manage; 2016 Jul; 31(3):e219-34. PubMed ID: 27523039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Historical Context of the Emergence of Health Systems Science (HSS): Changes in the U.S. Healthcare System and Medical Education from the 1910s to the 2010s.
    Kong HG
    Uisahak; 2023 Aug; 32(2):623-659. PubMed ID: 37718564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Building the Coverage Continuum: The Role of State Medicaid Directors and Insurance Commissioners.
    Ario J; Bachrach D
    Issue Brief (Commonw Fund); 2017 Feb; 4():1-10. PubMed ID: 28211994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Universal Health Insurance Coverage in Massachusetts Did Not Change the Trajectory of Arthroplasty Use or Costs.
    Kurtz SM; Lau E; Ong KL; Katz JN; Bozic KJ
    Clin Orthop Relat Res; 2016 May; 474(5):1090-8. PubMed ID: 26683036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of private payers in payment reform.
    Song Z; Chokshi DA
    JAMA; 2015 Jan; 313(1):25-6. PubMed ID: 25562259
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of privatized managed care on public insurance spending and generosity: Evidence from Medicaid.
    Perez V
    Health Econ; 2018 Mar; 27(3):557-575. PubMed ID: 29168257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the Impact of Health Insurance Industry Consolidation: Learning from Experience.
    Dafny LS
    Issue Brief (Commonw Fund); 2015 Nov; 33():1-11. PubMed ID: 26634241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why now is not the time for premium support.
    Aaron HJ; Frakt AB
    N Engl J Med; 2012 Mar; 366(10):877-9. PubMed ID: 22276779
    [No Abstract]   [Full Text] [Related]  

  • 13. Business, households, and government: health spending, 1994.
    Cowan CA; Braden BR; McDonnell PA; Sivarajan L
    Health Care Financ Rev; 1996; 17(4):157-78. PubMed ID: 10165707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthy competition--the why and how of "public-plan choice".
    Hacker JS
    N Engl J Med; 2009 May; 360(22):2269-71. PubMed ID: 19474422
    [No Abstract]   [Full Text] [Related]  

  • 15. The public sector-private sector interface: current issues, future trends.
    Surles RC; Shore MF
    New Dir Ment Health Serv; 1996; (72):71-9. PubMed ID: 8990873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential consequences of reforming Medicare into a competitive bidding system.
    Song Z; Cutler DM; Chernew ME
    JAMA; 2012 Aug; 308(5):459-60. PubMed ID: 22851110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of the development of managed health care in the South African private health care sector.
    Kinghorn AW
    S Afr Med J; 1996 Apr; 86(4):335-8. PubMed ID: 8693366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The out-of-network benefit: problems and policy solutions.
    Kyanko KA; Busch SH
    Inquiry; 2012-2013 Winter; 49(4):352-61. PubMed ID: 23469678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A profile of the health sector in the United States.
    Turner GM
    Pharmacoeconomics; 2002; 20 Suppl 3():31-45. PubMed ID: 12457423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanding choice through defined contributions: overcoming a non-participatory health care economy.
    Moffit RE
    J Law Med Ethics; 2012; 40(3):558-73. PubMed ID: 23061584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.